very positive - currently, there are no FDA-approved treatments. NNZ-2591 has the potential to fill this critical gap in healthcare.
- Forums
- ASX - By Stock
- NEU
- Ann: Fast Track granted by FDA for NNZ-2591 in Pitt Hopkins
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.04%
!
$13.24

Ann: Fast Track granted by FDA for NNZ-2591 in Pitt Hopkins, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.24 |
Change
0.390(3.04%) |
Mkt cap ! $1.652B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.177M | 318.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 95 | $13.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.25 | 465 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 51 | 13.260 |
4 | 211 | 13.250 |
5 | 561 | 13.240 |
7 | 764 | 13.230 |
4 | 1203 | 13.220 |
Price($) | Vol. | No. |
---|---|---|
13.280 | 339 | 3 |
13.290 | 598 | 4 |
13.300 | 1359 | 6 |
13.310 | 1257 | 4 |
13.320 | 1656 | 5 |
Last trade - 12.03pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online